back
SEDI Insider filing browser
| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2021-12-22 12:01 Tx date 2021-12-22 |
$IBT
IBEX TECHNOLOGIES INC. |
Connop, Bruce
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+75,000 vol |
150,000 | |
| Filed 2017-12-20 Tx date 2017-12-19 |
$IBT
IBEX TECHNOLOGIES INC. |
Connop, Bruce
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$15,000
+75,000 vol $0.20 each |
75,000 | |
| Filed 2017-12-20 Tx date 2017-10-11 |
$IBT
IBEX TECHNOLOGIES INC. |
Connop, Bruce
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2017-10-30 Tx date 2012-06-05 |
$
Transition Therapeutics Inc. |
Connop, Bruce
5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2017-10-30 Tx date 2012-06-05 |
$
Transition Therapeutics Inc. |
Connop, Bruce
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
350 | ||
| Filed 2017-10-30 Tx date 2012-06-05 |
$
Transition Therapeutics Inc. |
Connop, Bruce
5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
92,000 | ||
| Filed 2017-10-30 Tx date 2012-06-05 |
$
Transition Therapeutics Inc. |
Connop, Bruce
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2017-10-30 Tx date 2012-06-05 |
$
Transition Therapeutics Inc. |
Connop, Bruce
5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|